434 related articles for article (PubMed ID: 7015371)
21. Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.
Gemei M; Talarico C; Brandolini L; Manelfi C; Za L; Bovolenta S; Liberati C; Vecchio LD; Russo R; Cerchia C; Allegretti M; Beccari AR
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081372
[TBL] [Abstract][Full Text] [Related]
22. Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome.
Karmur BS; Philteos J; Abbasian A; Zacharia BE; Lipsman N; Levin V; Grossman S; Mansouri A
Front Oncol; 2020; 10():563840. PubMed ID: 33072591
[TBL] [Abstract][Full Text] [Related]
23. Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors.
Rasaeifar B; Gomez-Gutierrez P; Perez JJ
Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32967280
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Modeling of Bradykinin-Mediated Angioedema States.
Marceau F; Bachelard H; Charest-Morin X; Hébert J; Rivard GE
Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32824891
[TBL] [Abstract][Full Text] [Related]
25. A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors.
Lau J; Rousseau J; Kwon D; Bénard F; Lin KS
Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32824565
[TBL] [Abstract][Full Text] [Related]
26. PIP
Rivas-Ramírez P; Reboreda A; Rueda-Ruzafa L; Herrera-Pérez S; Lamas JA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936257
[TBL] [Abstract][Full Text] [Related]
27. The plasma metabolome of women in early pregnancy differs from that of non-pregnant women.
Handelman SK; Romero R; Tarca AL; Pacora P; Ingram B; Maymon E; Chaiworapongsa T; Hassan SS; Erez O
PLoS One; 2019; 14(11):e0224682. PubMed ID: 31726468
[TBL] [Abstract][Full Text] [Related]
28. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.
Arendse LB; Danser AHJ; Poglitsch M; Touyz RM; Burnett JC; Llorens-Cortes C; Ehlers MR; Sturrock ED
Pharmacol Rev; 2019 Oct; 71(4):539-570. PubMed ID: 31537750
[TBL] [Abstract][Full Text] [Related]
29. A Novel Bradykinin-Related Peptide, RVA-Thr
Wu Y; Shi D; Chen X; Wang L; Ying Y; Ma C; Xi X; Zhou M; Chen T; Shaw C
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31261655
[TBL] [Abstract][Full Text] [Related]
30. Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells.
Dagher OK; Jaffa MA; Habib A; Ziyadeh FN; Jaffa AA
PLoS One; 2019; 14(5):e0216908. PubMed ID: 31086419
[TBL] [Abstract][Full Text] [Related]
31. Bradykinin Type 1 Receptor - Inducible Nitric Oxide Synthase: A New Axis Implicated in Diabetic Retinopathy.
Othman R; Vaucher E; Couture R
Front Pharmacol; 2019; 10():300. PubMed ID: 30983997
[TBL] [Abstract][Full Text] [Related]
32. Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT
Anton EL; Fernandes D; Assreuy J; da Silva-Santos JE
Br J Pharmacol; 2019 Jul; 176(14):2608-2626. PubMed ID: 30945263
[TBL] [Abstract][Full Text] [Related]
33. Renal and vascular effects of kallikrein inhibition in a model of Lonomia obliqua venom-induced acute kidney injury.
Berger M; de Moraes JA; Beys-da-Silva WO; Santi L; Terraciano PB; Driemeier D; Cirne-Lima EO; Passos EP; Vieira MAR; Barja-Fidalgo TC; Guimarães JA
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007197. PubMed ID: 30763408
[TBL] [Abstract][Full Text] [Related]
34. Human tissue kallikrein in the treatment of acute ischemic stroke.
Alexander-Curtis M; Pauls R; Chao J; Volpi JJ; Bath PM; Verdoorn TA
Ther Adv Neurol Disord; 2019; 12():1756286418821918. PubMed ID: 30719079
[TBL] [Abstract][Full Text] [Related]
35. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Charest-Morin X; Hébert J; Rivard GÉ; Bonnefoy A; Wagner E; Marceau F
Front Immunol; 2018; 9():2183. PubMed ID: 30333824
[TBL] [Abstract][Full Text] [Related]
36. Conformationally Regulated Peptide Bond Cleavage in Bradykinin.
Fuller DR; Conant CR; El-Baba TJ; Brown CJ; Woodall DW; Russell DH; Clemmer DE
J Am Chem Soc; 2018 Aug; 140(30):9357-9360. PubMed ID: 30028131
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase Cε regulates nuclear translocation of extracellular signal-regulated kinase, which contributes to bradykinin-induced cyclooxygenase-2 expression.
Nakano R; Kitanaka T; Namba S; Kitanaka N; Sugiya H
Sci Rep; 2018 Jun; 8(1):8535. PubMed ID: 29867151
[TBL] [Abstract][Full Text] [Related]
38. D-Arg
Bachelard H; Charest-Morin X; Marceau F
Front Pharmacol; 2018; 9():273. PubMed ID: 29636689
[TBL] [Abstract][Full Text] [Related]
39. Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.
Sriramula S; Lazartigues E
Hypertension; 2017 Dec; 70(6):1122-1131. PubMed ID: 29038201
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the Bradykinin B
Asraf K; Torika N; Danon A; Fleisher-Berkovich S
Front Endocrinol (Lausanne); 2017; 8():82. PubMed ID: 28469598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
